山羊抗大鼠IgG H&L (HRP)预吸附二抗(ab98425)
Key features and details
- Goat Anti-Rat IgG H&L (HRP) preadsorbed
- Conjugation: HRP
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, ELISA, WB, ICC
概述
-
产品名称
山羊抗大鼠IgG H&L (HRP)预吸附二抗
参阅全部 IgG 二抗 -
宿主
Goat -
靶标种属
Rat -
经测试应用
适用于: IHC-P, ELISA, WB, ICCmore details -
最小交叉反应
Chicken, Cow, Goat, Horse, Human, Mouse, Rabbit, Sheep more details -
偶联物
HRP
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. -
存储溶液
pH: 6.8
Constituents: 0.2% BSA, 0.05% CMIT/MIT based preservative -
Concentration information loading...
-
纯度
Immunogen affinity purified -
纯化说明
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase. -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab98425于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
IHC-P |
1/200 - 1/5000.
|
|
ELISA |
1/10000 - 1/100000. (as Primary).
|
|
WB |
1/5000 - 1/50000. Colorimetric: 1/5000 - 1/30000; Chemiluminescent: 1/10000 - 1/50000.
|
|
ICC |
Use at an assay dependent dilution.
|
说明 |
---|
IHC-P
1/200 - 1/5000. |
ELISA
1/10000 - 1/100000. (as Primary). |
WB
1/5000 - 1/50000. Colorimetric: 1/5000 - 1/30000; Chemiluminescent: 1/10000 - 1/50000. |
ICC
Use at an assay dependent dilution. |
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (4)
ab98425 被引用在 4 文献中.
- Iida Y et al. AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk. Mol Clin Oncol 19:56 (2023). PubMed: 37323247
- Izutsu R et al. AMIGO2 contained in cancer cell-derived extracellular vesicles enhances the adhesion of liver endothelial cells to cancer cells. Sci Rep 12:792 (2022). PubMed: 35039535
- Goto K et al. Establishment of an antibody specific for AMIGO2 improves immunohistochemical evaluation of liver metastases and clinical outcomes in patients with colorectal cancer. Diagn Pathol 17:16 (2022). PubMed: 35094710
- Goto K et al. The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients. BMC Cancer 22:280 (2022). PubMed: 35296279